PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the "Company"), a health sciences company that develops innovative options for preventive and curative therapies ...

Synchronised implementation of multiple solutions is needed to ensure sustainability of dengue fever vaccines.

Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...

While much of the field focuses on disease modification, some agents are in development specifically to reduce OA pain.

GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic vaccine regimen failed to meet the efficacy endpoint | GSK has terminated a phase 1/2 hepatitis B trial after the therapeutic ...

Rates and yields have climbed in Latin America as imports soar, with freighters shifted elsewhere. Airports in Latin America ...

GSK partners with Duality Biologics in a $30 million upfront deal, potentially worth $975 million, for access to a ...

Vodafone Group PLC on Wednesday said the former chief financial officer of drugs maker GSK PLC will join its board as a non-executive director. The Berkshire, England-based telecommunications provider ...

Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease ...

South Korea Drug Delivery Devices Market is flourishing because of rising healthcare spending and the government’s support to provide support to promote development and adoption of medical devices.

Duality Biologics ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next-generation antibody-drug conjugate (ADC) therapeutics, today announced that it has ...

Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with ...